Vers une prévention de la démence?, Rev Neurol, vol.160, pp.256-260, 2004. ,
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function, Arch Neurol, vol.61, pp.378-384, 2004. ,
Long term donepezil treatment in 565 patients with Alzheimer' s disease (AD 2000): randomised double-blind trial, Lancet, vol.363, pp.2105-2115, 2004. ,
Alzheimer disease, JAMA, vol.287, pp.2335-2338, 2002. ,
Utilisation de la rivastigmine en pratique médicale courante chez des patients ambulatoires présentant une maladie d' Alzheimer, Rev Neurol, vol.158, pp.807-812, 2002. ,
La maladie d' Alzheimer, un problème de santé publique : oui ... une priorité?, Rev Neurol, vol.158, pp.311-315, 2002. ,
Les déficits cognitifs de la maladie d' Alzheimer, pp.183-197, 1997. ,
Atteintes neurochimiques de la maladie d' Alzheimer et recherche de modèles animaux, pp.53-81, 1997. ,
Pharmacokinetic profiles of current therapies for Alzheimer' s disease : implications for switching to galantamine, Clin Ther, vol.23, pp.13-24, 2001. ,
Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease, J Am Geriatr Soc, vol.51, pp.937-944, 2003. ,
Comparison studies of cholinesterase inhibitors for Alzheimer' s disease, Lancet neural, vol.3, pp.622-626, 2004. ,
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer' s disease, N Engl J Med, vol.345, pp.1515-1521, 2001. ,
Statins and the risk of dementia, Lancet, vol.356, pp.1627-1631, 2000. ,
La vie quotidienne du malade d 'Alzheimer, Editions Doin, p.79, 1995. ,
Benzodiazepine utilization patterns in Alzheimer's disease patints, Pharmacoepidemiol Drug Sa, vol.12, pp.511-515, 2003. ,
Profils mnésiques différents dans la démence à corps de Lewy et la maladie d' Alzheimer débutante, Rev Neurol, vol.159, pp.762-766, 2003. ,
Memory loss, when is it Alzheimer's disease?, JAMA, vol.279, pp.1689-1690, 1998. ,
The cognitive benefits of galantamine are sustained for at least 36 months, a long term extension trial, Arch Neurol, vol.61, pp.252-256, 2004. ,
Prise en charge thérapeutique de la démence, EMC Méd, vol.2, pp.145-151, 2005. ,
Efficacity and tolerability of memantine in the treatment of dementia, Am J Geriatr Pharmacother, vol.2, pp.303-312, 2004. ,
Treatment of Alzheimer' s disease: current status and new perspectives, Lancet neural, vol.2, pp.539-547, 2003. ,
Efficacity of donepezil in early-stage Alzheimer disease, Arch Neurol, vol.61, pp.1852-1856, 2004. ,
Pharmacological treatment of neuropsychiatrie symptoms of dementia, JAMA, vol.293, pp.596-608, 2005. ,
Dementia of Alzheimer's disease and other neurodegenerative disorders: memantine, a new hope, PharmacolRes, vol.51, pp.1-17, 2005. ,
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil, JAMA, vol.291, pp.317-324, 2004. ,
Exercise plus behavioral management in patients with Alzheimer disease, JAMA, vol.290, pp.2015-2022, 2003. ,
Démences à corps de Lewy, Editions Doin, pp.193-201, 2002. ,
Efficacity of cholinesterase inhibitors in the treatment of neuropsychiatrie symptoms and functional impairment in Alzheimer disease, JAMA, vol.289, pp.210-216, 2003. ,
A review of rivastigmine: a reversible cholinesterase inhibitor, Clin Ther, vol.25, pp.1634-1653, 2003. ,
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements, Arch Neural, vol.61, pp.82-88, 2004. ,
The management of psychogeriatric patient, Arch Gerontol Geriatr, vol.9, pp.465-470, 2004. ,
79-Interactions médicamenteuses : nouveautés 2002, Rev Prescrire, vol.22, pp.436-439, 2002. ,
!ltc 4'lll' lu date ~imp!~c d..'m.1j<:>tud'fali? ___________ _ 2 ,
1~r t1U.:CS'lttti?!ll §ll:lf n.'t!df<Jiil ni): llGU!i tl\li!\'l)!iiii ,
4'1.?Ïl '! lt Qud t1ti 1<i nom th1 daus l'lltquc! am xi!li1 ,